Healthcare & Medical Investment Corporation (TYO:3455)
Japan · Delayed Price · Currency is JPY 96,200
-800 (-0.82%)
Last updated: Aug 28, 2026, 11:30 AM JST
TYO:3455 Balance Sheet
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Property, Plant & Equipment | 84,265 | 81,081 | 78,042 | 78,789 | 66,759 |
Cash & Equivalents | 2,524 | 2,109 | 1,865 | 1,540 | 1,689 |
Accounts Receivable | 46.65 | 46.92 | 50.26 | 51.05 | 2 |
Other Receivables | 10.98 | - | - | - | - |
Investment In Debt and Equity Securities | 197.02 | 102.49 | - | - | - |
Other Intangible Assets | 0.82 | 1.47 | 2.12 | 2.77 | - |
Restricted Cash | 132.02 | 115.22 | 109.26 | 104.54 | 181 |
Other Current Assets | 418.54 | 371.42 | 306.89 | 312.59 | 129 |
Deferred Long-Term Tax Assets | 0.01 | 0.01 | 0.01 | 0 | - |
Deferred Long-Term Charges | 8.33 | 10.41 | 23.97 | 37.54 | - |
Other Long-Term Assets | 1,182 | 768.71 | 314.82 | 406 | 18 |
Total Assets | 88,786 | 84,606 | 80,715 | 81,243 | 68,778 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Current Portion of Long-Term Debt | 5,900 | 6,400 | 5,550 | 7,250 | 9,250 |
Long-Term Debt | 38,700 | 35,250 | 31,600 | 29,900 | 23,900 |
Accounts Payable | 68.28 | 61.81 | 63.78 | 55.68 | 184 |
Accrued Expenses | 296.81 | 303.57 | 282.25 | 400.82 | 240 |
Current Income Taxes Payable | 0.69 | 0.87 | 0.9 | 0.7 | - |
Other Current Liabilities | 523.49 | 518.44 | 493.08 | 501.16 | 342 |
Long-Term Deferred Tax Liabilities | 289.21 | 146.57 | 25.72 | 47.32 | 10 |
Other Long-Term Liabilities | 2,331 | 2,153 | 2,162 | 2,119 | 1,985 |
Total Liabilities | 50,080 | 46,004 | 42,178 | 42,275 | 35,911 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Common Stock | 38,324 | 38,324 | 38,324 | 38,324 | 31,948 |
Retained Earnings | 1,058 | 1,025 | 1,101 | 1,290 | 929 |
Comprehensive Income & Other | -675.58 | -746.19 | -887.72 | -645.37 | -10 |
Shareholders' Equity | 38,706 | 38,602 | 38,537 | 38,968 | 32,867 |
Total Liabilities & Equity | 88,786 | 84,606 | 80,715 | 81,243 | 68,778 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Total Debt | 46,570 | 42,820 | 39,150 | 39,150 | 33,150 |
Net Cash (Debt) | -44,046 | -40,711 | -37,285 | -37,610 | -31,461 |
Net Cash (Debt) Growth | - | - | - | - | - |
Net Cash Per Share | -122518.79 | -113244.08 | -103712.73 | -104669.98 | -101160.45 |
Filing Date Shares Outstanding | 0.36 | 0.36 | 0.36 | 0.36 | 0.31 |
Total Common Shares Outstanding | 0.36 | 0.36 | 0.36 | 0.36 | 0.31 |
Book Value Per Share | 107666.51 | 107378.03 | 107196.07 | 108395.70 | 105681.33 |
Tangible Book Value | 38,705 | 38,601 | 38,535 | 38,965 | 32,867 |
Tangible Book Value Per Share | 107664.24 | 107373.94 | 107190.18 | 108387.99 | 105681.33 |
Land | 48,144 | 45,695 | 43,748 | 43,748 | - |
Buildings | 44,803 | 42,889 | 40,680 | 40,365 | - |
Construction In Progress | 6.49 | - | - | - | - |